Calmare Pain Relief Solutions Adds New Calmare(R) Pain Therapy Clinics
05 Noviembre 2013 - 12:19PM
Marketwired
Calmare Pain Relief Solutions Adds New Calmare(R) Pain Therapy
Clinics
Broadens Reach With New and Improved Web Presence
STATEN ISLAND, NY--(Marketwired - Nov 5, 2013) - Calmare Pain
Relief Solutions (the "Company"), a chronic pain treatment medical
practice, will increase its Calmare Pain Therapy clinic network by
70% in the Tri-state area in 2014. This expansion is in response to
the U.S. Food and Drug Administration's (FDA) position regarding
the benefits of using a non-narcotic solution for the relief of
chronic pain. This position was highlighted in a recent New York
Times article entitled "FDA Shift on Painkillers was Years in the
Making."
With the increased acceptance of Calmare Pain Therapy by
nationwide insurance companies, there has been an increase in new,
chronic pain patient visitors to the Calmare Pain Relief Solutions'
network of clinics. Their search for a non-invasive and
non-narcotic pain relief regimen has resulted in the Company's
redesigned corporate website. The site now offers chronic pain
sufferers a web portal that houses a repository of information on
the Calmare technology (commonly known as "Scrambler" technology).
Visitors can view media reports and videos on the potential
benefits gained from this alternative therapy versus a traditional
biochemical solution. They can also read articles and research
documents that may assist patients and healthcare providers in
assessing the benefits of this technology.
"We wanted to offer patients and insurance companies a very
informative website on the Calmare pain relief therapy," said David
J. Palmieri, healthcare consultant to Calmare Pain Relief
Solutions. "We often get requests for well-referenced information
from patients and insurance providers and our new website is a
direct response to those requests."
About Calmare® Pain Therapy ("Scrambler" Therapy) The Calmare®
pain therapy device, commonly known as a "Scrambler" therapy
machine, is a patented and proprietary, U.S. FDA 510(k)-cleared and
European CE mark-certified pain medical device for the non-invasive
and non-narcotic treatment of chronic neuropathic and oncologic
pain. The medical device uses a multi-processor that creates a new
pain association signal from pain source to brain, which replaces a
"pain" signal with a "no-pain" signal. The new "no-pain" signal is
delivered to the brain through surface electrodes, and can provide
immediate to long-lasting pain relief for the patient.
Distributed by its licensee Competitive Technologies, Inc.
(OTCQX: CTTC), the Calmare pain therapy has been administered to
thousands of patients worldwide. It has shown efficacy in treating
neuropathic and oncologic pain. Today, through a general services
administration (GSA) preferred vendor number, Calmare is used
throughout US military and Veterans Administration (VA)
hospitals.
About Our Physicians The physicians at Calmare Pain Relief
Solutions, Christopher Perez, MD and Jack D'Angelo, MD, have
been treating chronic pain patients suffering from neuropathies
such as failed back surgery, Reflex Sympathetic Dystrophy
(RSD/CRPS), and Chemotherapy-induced Peripheral Neuropathy (CIPN)
since 2010.
About Calmare Pain Relief Solutions Calmare Pain Relief
Solutions is a Physician group which specializes in offering a
non-narcotic and non-invasive solution for chronic pain.
Christopher Perez, MD and Jack D'Angelo, MD, specialize in physical
medicine and rehabilitation and together have over 30 years of
clinical experience treating chronic neuropathic pain.
For more information David Palmieri (800) 899-0574
CalmareRelief@gmail.com www.CalmareRelief.com
Calmare Therapeutics (CE) (USOTC:CTTC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Calmare Therapeutics (CE) (USOTC:CTTC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024